|
WO2020227312A1
|
|
Synthesis of crac channel inhibitors
|
|
EP3573610A1
|
|
Crac channel inhibitor compositions
|
|
AU2016306301A1
|
|
Use of CRAC channel inhibitors for the treatment of stroke and traumatic brain injury
|
|
KR20180006880A
|
|
Pancreatitis treatment
|
|
US2015322012A1
|
|
Compounds that modulate intracellular calcium
|
|
WO2015054283A1
|
|
Compounds that modulate intracellular calcium
|
|
WO2014059333A1
|
|
Compounds that modulate intracellular calcium
|
|
WO2014043715A1
|
|
Compounds that modulate intracellular calcium
|
|
US2014187616A1
|
|
Calcium channel proteins and uses thereof
|
|
WO2013059677A1
|
|
Compounds that modulate intracellular calcium
|
|
WO2013059666A1
|
|
Compounds that modulate intracellular calcium
|
|
WO2012040511A2
|
|
Compounds that modulate intracellular calcium
|
|
CN103180316A
|
|
Compounds that modulate intracellular calciu
|
|
AU2011248579A1
|
|
Compounds that modulate intracellular calcium
|
|
HUE029570T2
|
|
Compounds that modulate intracellular calcium
|
|
WO2011109551A2
|
|
Compounds that modulate intracellular calcium
|
|
EP2477982A2
|
|
Compounds that modulate intracellular calcium
|
|
US2011230536A1
|
|
Phenylpyrazole inhibitors of store operated calcium release
|
|
WO2010034011A2
|
|
Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release
|
|
WO2010034003A2
|
|
Benzylthiotetrazole inhibitors of store operated calcium release
|
